MedPath

EFFECT OF INTRAVENOUS TRANEXAMIC ACID IN REDUCING BLOOD LOSS DURING AND AFTER ELECTIVE CAESAREAN SECTION IN THE UNIVERSITY OF PORT HARCOURT TEACHING HOSPITAL: A RANDOMIZED CONTROLLED STUDY

Phase 4
Conditions
Blood loss during and after caesarean section
Registration Number
PACTR202011872201172
Lead Sponsor
JEMIRIGBE OMAWUMI DARLINGTO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
148
Inclusion Criteria

Age between 20 to 40 years.
Parity- 1 - 4
Gestational age of 37-40 weeks.
Singleton live fetus with reassuring fetal heart rate.
Elective repeat CS.

Exclusion Criteria

Refusal of the patient to give consent.
Known allergy to intravenous tranexamic acid.
Multiple pregnancies.
Antepartum haemorrhage.
Co-existing uterine fibroids.
Macrosomic baby- birth weight =4kg.
Intrauterine fetal death.
Preeclampsia.
Others are history of thromboembolic disease, medical conditions such as major liver, heart, kidney, brain and bleeding disorders, anticoagulant therapy, patients requiring blood transfusion due to anaemia and polyhydramnios. The medical conditions will be excluded from thorough history and examination of the patient and those with a positive history and examination findings suggestive of these medical conditions will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of blood loss during and after caesarean section.
Secondary Outcome Measures
NameTimeMethod
Additional uterotonic drugs.;2.Blood transfusion. ;3.Surgical interventions.;Maternal and fetal side effects.
© Copyright 2025. All Rights Reserved by MedPath